• Editorial Board

    Nov 5, 2025, 08:27

  • Table of Contents

    Nov 1, 2025, 00:00

  • Psychometric Validation of EQ-5D-5L in Individuals With Chronic Spinal Cord Injury in China

    Nov 1, 2025, 00:00

  • Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients

    Nov 1, 2025, 00:00

  • Disseminated Histoplasmosis in People Living With HIV: What Are the Care Costs for Brazil?

    Nov 1, 2025, 00:00

  • Medicines Policy in Action: The Impact on Volume and Cost of Biologic Medicines After Biosimilar Introduction

    Nov 1, 2025, 00:00

  • Cost-Effectiveness Analysis Comparing Ceftazidime/Avibactam With Standard of Care in the Treatment of Hospital and Ventilator-Acquired Pneumonia in the Philippines

    Nov 1, 2025, 00:00

  • Valuation of the Alzheimer’s Disease 5 Dimensions Instrument: A Discrete Choice Experiment With Life Duration in Chile

    Nov 1, 2025, 00:00

  • Impact of Severe Hemophilia on Costs and Quality of Life in South American Men: Findings From the CHESS LATAM Study

    Nov 1, 2025, 00:00

  • Comparison of Cancer Registry Data Between Sweden and China and the Impact on Real-World Health Research

    Nov 1, 2025, 00:00

  • Epidemiology, Real-World Treatment, and Economic Burden of Waldenström Macroglobulinemia: A Comprehensive Analysis Based on Anonymized Claims Data Between 2010 and 2022

    Nov 1, 2025, 00:00

  • Cost and Budget Impact of Layering Depression Care Onto Existing HIV and Noncommunicable Disease Care Services in Western Kenya

    Nov 1, 2025, 00:00

  • Healthcare Costs and Main Characteristics of Childbirth and Neonatal Inpatient Care From the Brazilian Public Health System Perspective

    Nov 1, 2025, 00:00

  • Correction

    Nov 1, 2025, 00:00

  • Cost Analysis of Diabetes Mellitus Treatment in the Public Sector in Dubai, The United Arab Emirates: Analysis Based on a Global Perspective Model

    Nov 1, 2025, 00:00

  • Cost-Utility Analysis of Expanding Human Papillomavirus Vaccination to Adult Women in Indonesia: A Markov Model Approach

    Nov 1, 2025, 00:00

  • Self-Reported Health-Related Quality of Life in Patients With Ischemic Heart Disease: A Randomized Controlled Trial on Digital Health Pharmacist Interventions

    Nov 1, 2025, 00:00

  • Disclaimer

    Oct 23, 2025, 09:07

  • RWD40 EVALUATING THE REPRESENTATIVENESS OF A REAL-WORLD ONCOLOGY DATABASE DEVELOPED BY THE J-CONNECT CONSORTIUM: COMPARISON WITH JAPAN'S NATIONAL CANCER REGISTRY

    Oct 1, 2025, 00:00

  • RWD76 POTENTIAL RISK OF ACUTE PANCREATITIS WITH GLP-1 RECEPTOR AGONISTS

    Oct 1, 2025, 00:00

  • RWD42 ECONOMIC EVALUATION OF NEOADJUVANT-ADJUVANT VERSUS ADJUVANT-ONLY PEMBROLIZUMAB IN RESECTABLE MELANOMA

    Oct 1, 2025, 00:00

  • RWD292 PREFERENCE FOR VIRTUAL REALITY EXERGAME IN WEIGHT CONTROL SETTING AMONG YOUNG ADULTS: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD248 DRUG SURVIVAL, SWITCHING PATTERN, AND COSTS OF MODERATE TO SEVERE PSORIASIS PATIENTS TREATED WITH BIOLOGICS IN CHINA

    Oct 1, 2025, 00:00

  • RWD307 EXPLORING LONG COVID IN TAIWANESE CHILDREN: IMMUNOLOGICAL INSIGHTS AND CLINICAL IMPACTS

    Oct 1, 2025, 00:00

  • RWD51 CONSENSUS-BASED GUIDANCE FOR BONE HEALTH OPTIMIZATION IN SPINE SURGERY

    Oct 1, 2025, 00:00

  • RWD23 RESEARCH ON THE DRIVING MECHANISM OF CORPORATE PARTICIPATION IN GOVERNANCE FOR HEALTH—AN EMPIRICAL ANALYSIS BASED ON CHINESE LISTED COMPANIES

    Oct 1, 2025, 00:00

  • RWD64 REAL-WORLD ANALYSIS OF HEALTHCARE RESOURCE UTILIZATION IN PATENTS WITH CORONARY ARTERY DISEASE UNDERGOING PACLITAXEL-COATED BALLOON ANGIOPLASTY WITH AND WITHOUT INTRAVASCULAR ULTRASOUND GUIDANCE

    Oct 1, 2025, 00:00

  • RWD87 ANALYSIS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE MEDICATIONS BASED ON REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • Peer Reviewers

    Oct 1, 2025, 00:00

  • RWD142 ANALYSIS OF IMPLEMENTATION AND TERMINATION CHARACTERISTICS OF MANAGED ENTRY AGREEMENTS FOR NEW DRUGS UNDER TAIWAN’S NATIONAL HEALTH INSURANCE SYSTEM

    Oct 1, 2025, 00:00

  • RWD158 PERFORMANCE OF CHATGPT-4O AND CLAUDE 3.5 SONNET IN TITLE AND ABSTRACT SCREENING FOR A SYSTEMATIC REVIEW IN OBSTETRICS

    Oct 1, 2025, 00:00

  • RWD131 COST-EFFECTIVENESS OF DOSTARLIMAB PLUS CHEMOTHERAPY FOR PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCER FROM TAIWAN’S NATIONAL HEALTH INSURANCE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD298 PUBLIC HEALTH IMPACT ASSESSMENT OF RSVPREF3 OA ADJUVANTED VACCINE ON RESPIRATORY SYNCYTIA VIRUS IN TAIWAN, HONG KONG, AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD69 HEALTHCARE COSTS AND RESOURCE UTILIZATION OF PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA: A NATIONWIDE POPULATION-BASED STUDY IN TAIWAN, 2017–2022

    Oct 1, 2025, 00:00

  • RWD25 ASSOCIATION BETWEEN BARRIERS TO ACCESSING GENERAL PRACTITIONERS AND EMERGENCY DEPARTMENT VISITS IN NEW ZEALAND

    Oct 1, 2025, 00:00

  • RWD153 ECONOMIC EVALUATIONS OF ORPHAN DRUGS FOR RARE KIDNEY DISEASES IN LOW AND MIDDLE INCOME COUNTRIES: A SYSTEMATIC REVIEW AND BIBLIOMETRIC ANALYSIS

    Oct 1, 2025, 00:00

  • RWD38 PRESCRIPTION PATTERN AND COSTS OF ANTIDIABETIC MEDICATIONS IN PATIENTS WITH TYPE 2 DIABETES BY SPECIALIST PHYSICIANS AND NON-SPECIALIST PHYSICIANS

    Oct 1, 2025, 00:00

  • RWD36 DEVELOPMENT OF A STANDARDIZED MULTICENTER KNEE OSTEOARTHRITIS DATABASE IN JAPAN: INSIGHTS FROM A NEW REAL-WORLD DATABASE

    Oct 1, 2025, 00:00

  • RWD240 COST-EFFECTIVENESS ANALYSIS OF ADJUVANT ATEZOLIZUMAB OR PEMBROLIZUMAB IN STAGE II-IIIA NON-SMALL CELL LUNG CANCER PATIENTS WITH PD-L1 ≥1% EXPRESSING IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD74 USE OF RWE TO INFORM SURVIVAL EXTRAPOLATION IN HEALTH ECONOMIC APPRAISALS OF CANCER DRUGS IN SWEDEN: A REVIEW OF NATIONAL HEALTH ECONOMIC REPORTS 2010-2024

    Oct 1, 2025, 00:00

  • RWD285 COST-UTILITY ANALYSIS OF ECULIZUMAB FOR ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) IN THAILAND

    Oct 1, 2025, 00:00

  • RWD274 ECONOMIC EVALUATION OF USING A UNIT DOSE DISPENSING ROBOT IN A THAI TERTIARY HOSPITAL

    Oct 1, 2025, 00:00

  • RWD299 HEALTHCARE UTILIZATION AMONG COVID-19 PATIENTS TREATED WITH NIRMATRELVIR/RITONAVIR IN TAIWAN: A NATIONWIDE POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD257 HEALTH SAVINGS IMPACT OF MULTIVITAMIN SUPPLEMENTATION IN TAIWAN: A DEMENTIA RISK REDUCTION ECONOMIC MODEL

    Oct 1, 2025, 00:00

  • Research Presentations Financial Disclosure Statements

    Oct 1, 2025, 00:00

  • RWD151 COMPARATIVE ANALYSIS OF HTA GUIDELINES ON INDIRECT COSTS AND CAREGIVER UTILITIES: JAPAN VS. FOUR EUROPEAN COUNTRIES

    Oct 1, 2025, 00:00

  • RWD89 ASSESSING EARLY ADOPTION OF PULSED FIELD ABLATION FOR THE TREATMENT OF ATRIAL FIBRILLATION USING CLAIMS AND HOSPITAL CHARGE DATA

    Oct 1, 2025, 00:00

  • RWD140 REAL-WORLD UTILIZATION, PERSISTENCE, AND EFFECTIVENESS OF BIOLOGIC THERAPIES IN PATIENTS WITH SEVERE ASTHMA: A MULTICENTER RETROSPECTIVE COHORT STUDY IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD247 GEOGRAPHIC DISPARITIES IN ACCESS TO NATIONALLY NEGOTIATED ANTICANCER MEDICINES IN CHINA

    Oct 1, 2025, 00:00

  • RWD252 EVALUATING THE COST-EFFECTIVENESS OF TUMOR-TREATING FIELDS IN COMBINATION WITH TEMOZOLOMIDE FOR GLIOBLASTOMA IN SINGAPORE

    Oct 1, 2025, 00:00

  • RWD68 ASSESSMENT OF SEASONAL VARIATION IN THE PERFORMANCE OF FECAL IMMUNOCHEMICAL TESTING FOR COLORECTAL CANCER SCREENING

    Oct 1, 2025, 00:00

  • RWD30 DETERMINANTS OF WILLINGNESS TO ACCEPT THE PNEUMOCOCCAL VACCINE: AN POPULATION-BASED STUDY IN HONG KONG

    Oct 1, 2025, 00:00

  • RWD122 COST-EFFECTIVENESS ANALYSIS OF PRENATAL DIAGNOSTIC STRATEGIES AMONG KOREAN PREGNANT WOMEN

    Oct 1, 2025, 00:00

  • RWD22 MINDFULNESS-BASED INTERVENTIONS FOR PSYCHOLOGICAL DISTRESS IN LUNG CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD59 THE HEALTHCARE AND ECONOMIC BURDEN ASSOCIATED WITH INADEQUATE RISK FACTOR CONTROL FOR TYPE 2 DIABETES IN HONG KONG: A POPULATION-BASED MODELLING STUDY

    Oct 1, 2025, 00:00

  • RWD175 EVALUATING THE DISEASE SPECTRUM AND COST OF CARE AMONG NEUROLOGY INPATIENTS IN NORTHEAST INDIA: INSIGHTS FROM A REAL WORLD, HOSPITAL BASED STUDY

    Oct 1, 2025, 00:00

  • RWD138 A PRACTICAL APPROACH TO IDENTIFYING EARLY NEONATAL CONDITIONS IN A DE-IDENTIFIED DATABASE: NATIONAL HEALTH INSURANCE RESEARCH DATABASE (NHIRD)

    Oct 1, 2025, 00:00

  • RWD283 COST-EFFECTIVENESS ANALYSIS OF DURVALUMAB AND ATEZOLIZUMAB WITH CHEMOTHERAPY VERSUS CHEMOTHERAPY ALONE FOR FIRST-LINE TREATMENT OF EXTENSIVE-STAGE SMALL-CELL LUNG CANCER IN TAIWAN

    Oct 1, 2025, 00:00

  • RWD276 EXPLORING THE ASSOCIATIONS BETWEEN NEWER GLUCOSE-LOWERING DRUGS USE AND COGNITIVE FUNCTION DECLINE IN ADULTS WITH DIABETES: A TARGET TRIAL EMULATION

    Oct 1, 2025, 00:00

  • RWD49 AN EQ-5D MULTILAYERED MEASURE OF HEALTH-RELATED QUALITY OF LIFE: IS THERE RELEVANCE AND NEED FOR IT?

    Oct 1, 2025, 00:00

  • RWD188 ADOPTION AND CHALLENGES OF ELECTRONIC CLINICAL OUTCOME ASSESSMENTS AND PATIENT-REPORTED OUTCOMES IN CHINA: INSIGHTS FROM A SURVEY OF HEALTHCARE PROFESSIONALS AND INDUSTRY STAKEHOLDERS

    Oct 1, 2025, 00:00

  • RWD193 DEMOGRAPHIC AND LIFESTYLE DETERMINANTS OF SCREEN USE PATTERNS IN HONG KONG SECONDARY SCHOOL STUDENTS

    Oct 1, 2025, 00:00

  • RWD320 COST-EFFECTIVENESS OF RIBOCICLIB PLUS LETROZOLE FOR PREMENOPAUSAL WOMEN WITH HR+/HER2- ADVANCED BREAST CANCER IN THAILAND: A SOCIETAL PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD199 A MOBILE-ACCESSIBLE COST-EFFECTIVE AI-AIDED SELF-ASSESSMENT TOOL FOR EARLY MEASLES DETECTION IN LOW-RESOURCE SETTINGS

    Oct 1, 2025, 00:00

  • RWD105 A REVIEW OF THE CHALLENGES AND OPPORTUNITIES FOR THE USE OF REAL-WORLD EVIDENCE FOR MEDICAL DEVICES IN JAPAN

    Oct 1, 2025, 00:00

  • RWD192 IMPLEMENTATION OF OSTEOPOROSIS SCREENING IN HONG KONG: PERSPECTIVES OF HEALTHCARE PROVIDERS THROUGH THE LENS OF THE CONSOLIDATED FRAMEWORK FOR IMPLEMENTATION RESEARCH

    Oct 1, 2025, 00:00

  • RWD104 EVALUATING FERTILITY TREATMENT COSTS IN JAPAN: A MICRO-COSTING ANALYSIS

    Oct 1, 2025, 00:00

  • RWD196 THE ROLE OF FOOD LABEL USE IN ENHANCING HEALTHCARE DECISION-MAKING AMONG PATIENTS WITH CHRONIC METABOLIC DISEASES

    Oct 1, 2025, 00:00

  • RWD106 PREDICTION OF RARE DISEASE MEDICATION TRANSITION PATTERNS BASED ON AN INTERPRETABLE MACHINE LEARNING MODEL

    Oct 1, 2025, 00:00

  • RWD82 LEVERAGING REAL-WORLD DATA (RWD) TO INFORM DRUG REIMBURSEMENT IN ASIA-PACIFIC: ADDRESSING CHALLENGES AND BUILDING SOLUTIONS

    Oct 1, 2025, 00:00

  • RWD195 ESTIMATING THE AVERAGE TREATMENT EFFECT AMONG PATIENTS WITH HEART FAILURE USING TARGETED MAXIMUM LIKELIHOOD ESTIMATION: IMPLICATIONS FROM A LARGE-SCALE HEALTH ADMINISTRATIVE DATABASE

    Oct 1, 2025, 00:00

  • RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES

    Oct 1, 2025, 00:00

  • RWD255 IMPORTANT FEATURES OF TELEREHABILITATION FOR MUSCULOSKELETAL PATIENTS: APPLYING AN IMPLEMENTATION SCIENCE FRAMEWORK TO INFORM THE SELECTION OF ATTRIBUTES FOR DISCRETE CHOICE EXPERIMENTS

    Oct 1, 2025, 00:00

  • RWD225 COST-EFFECTIVENESS OF DOCETAXEL VERSUS IMMUNE CHECKPOINT INHIBITORS AS TREATMENT FOR ADVANCED/METASTATIC NON-SMALL CELL LUNG CANCER: A TARGETED LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD34 GENERATING REAL-WORLD UTILITY VALUES FOR PEDIATRIC HEALTH STATES IN TAIWAN: A NATIONWIDE EQ-5D-Y-3L VALUATION STUDY USING COMPOSITE TIME TRADE-OFF

    Oct 1, 2025, 00:00

  • RWD77 HEALTHCARE UTILIZATION PATTERNS IN EARLY-STAGE BREAST CANCER TAIWANESE PATIENTS: A REAL WORLD EVIDENCE-BASED SUBTYPE-SPECIFIC STUDY

    Oct 1, 2025, 00:00

  • RWD253 FORECASTING SURVIVAL IN NASOPHARYNGEAL CANCER PATIENTS WITH DIABETES THROUGH MACHINE LEARNING: A POPULATION-BASED ANALYSIS

    Oct 1, 2025, 00:00

  • RWD219 SYMPTOM NETWORKS OF DEPRESSION AND ANXIETY IN PATIENTS WITH A HISTORY OF HEMORRHOIDS: EVIDENCE FROM THE UK BIOBANK

    Oct 1, 2025, 00:00

  • RWD204 COMPARATIVE OUTCOMES OF INDWELLING PERITONEAL CATHETERS (IPCS) VERSUS LARGE VOLUME PARACENTESIS (LVP) IN THE MANAGEMENT OF MALIGNANT AND NON-MALIGNANT ASCITES: A SYSTEMATIC LITERATURE REVIEW

    Oct 1, 2025, 00:00

  • RWD260 A COMPARATIVE ANALYSIS OF THE REDAPT SYSTEM IN REVISION TOTAL HIP ARTHROPLASTY: EVIDENCE FROM A LARGE US CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD91 DIRECT MEDICAL COSTS OF NASOPHARYNGEAL CARCINOMA IN INDONESIA: A HEALTHCARE PAYER PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD162 DEVELOPMENT AND VALIDATION OF A PREDICTIVE MODEL FOR THE RISK OF SARCOPENIA IN PATIENTS WITH COPD

    Oct 1, 2025, 00:00

  • RWD300 CLINICAL SAFETY ANALYSIS OF AMINOPHYLLINE INJECTION: A RETROSPECTIVE COHORT STUDY BASED ON ELECTRONIC HEALTH RECORDS IN CHINA

    Oct 1, 2025, 00:00

  • RWD146 ASSOCIATION BETWEEN FRAILTY STATUS AND GLYCEMIC CONTROL IN MIDDLE-AGED AND OLDER ADULTS WITH TYPE 2 DIABETES: A CROSS-SECTIONAL ANALYSIS OF THE UK BIOBANK COHORT

    Oct 1, 2025, 00:00

  • RWD92 STATIN USE AND THE PROGRESSION OF PARKINSON’S DISEASE: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD290 EVALUATING THE RATIONAL USE OF DISEASE MODIFYING THERAPIES FOR RELAPSING REMITTING MULTIPLE SCLEROSIS USING CLAIMS DATA

    Oct 1, 2025, 00:00

  • RWD270 ENHANCING CAUSAL DISCOVERY IN CHRONIC DISEASES: THE MAGIC FRAMEWORK USING MULTIPLE LLMS

    Oct 1, 2025, 00:00

  • RWD62 TREATMENT PATTERNS FOR CHEMOTHERAPY-INDUCED ANEMIA IN CHINESE POPULATION: A MULTI-CENTER RETROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD66 HEALTH-RELATED QUALITY OF LIFE AND ITS DETERMINANTS AMONG INDIVIDUALS WITH SPINAL CORD INJURY IN CHINA: EXPLORATORY ANALYSES FROM TWO NATIONAL SURVEYS

    Oct 1, 2025, 00:00

  • RWD121 COMPARISON OF THE EFFECTIVENESS OF DEFOCUS SPECTACLE LENSES IN SLOWING MYOPIA PROGRESSION: A RETROSPECTIVE COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD112 ECONOMIC EVALUATION OF SELUMETINIB FOR TREATING PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 INOPERABLE PLEXIFORM NEUROFIBROMAS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD243 EFFECT OF ANGIOTENSIN II RECEPTOR BLOCKERS ON ALZHEIMER'S DISEASE PROGRESSION: A POPULATION-BASED COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD37 ADOPTING A CLOSED INTEGRATED PERIPHERAL INTRAVENOUS CANNULA SYSTEM IN AN AUSTRALIAN HOSPITAL: CLINICAL AND ECONOMIC IMPACT

    Oct 1, 2025, 00:00

  • RWD147 FACTORS INFLUENCING DRUG GUIDANCE OUTCOMES IN SINGAPORE: A REVIEW OF 2023-2024 APPRAISALS

    Oct 1, 2025, 00:00

  • RWD171 RESEARCH ON STAKEHOLDER COLLABORATION MECHANISM FOR MEDICAL DATA SHARING: A THREE-PARTY EVOLUTIONARY GAME ANALYSIS

    Oct 1, 2025, 00:00

  • RWD7 GLOBAL INCIDENCE, RISK FACTORS, AND TRENDS OF PHARYNGEAL CANCER BY ANATOMICAL SITES: A SYSTEMATIC ANALYSIS OF CANCER REGISTRIES

    Oct 1, 2025, 00:00

  • RWD256 COMPARATIVE EFFECTS OF SMOKING CESSATION INTERVENTION FOR ADOLESCENTS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD88 RISK OF ZOLPIDEM USE IN ADOLESCENTS: ANALYSIS OF NHIS DATABASE IN KOREA

    Oct 1, 2025, 00:00

  • RWD280 THE LONG-TERM EFFECTS OF OPIOID USE BEFORE TOTAL JOINT REPLACEMENT SURGERY: A DOSE-RESPONSE TRIAL EMULATION USING NEW ZEALAND LINKED ADMINISTRATIVE DATA

    Oct 1, 2025, 00:00

  • RWD1 FROM INFECTION TO RECOVERY: HEALTH-RELATED QUALITY OF LIFE TRAJECTORIES AMONG COVID-19 PATIENTS IN SELANGOR

    Oct 1, 2025, 00:00

  • RWD94 ASSOCIATION BETWEEN USE OF A MULTIDISCIPLINARY NURSE- AND ALLIED HEALTH-LED MANAGEMENT SERVICE FOR COPD AND SUBSEQUENT HOSPITALIZATION DUE TO AMBULATORY CARE SENSITIVE CONDITIONS

    Oct 1, 2025, 00:00

  • RWD72 EVALUATING THE OPTIMAL AGE FOR NATIONAL GASTRIC CANCER SCREENING IN KOREA: A REAL-WORLD, POPULATION-BASED COHORT

    Oct 1, 2025, 00:00

  • RWD24 ACCEPTANCE OF REAL-WORLD EVIDENCE IN HTA IN JAPAN: IS THE POTENTIAL BEING REALIZED?

    Oct 1, 2025, 00:00

  • RWD245 ARTIFICIAL INTELLIGENCE-POWERED IDENTIFICATION, ACCESS, AND UTILITY MAPPING OF REAL-WORLD DATA SOURCES FOR LUNG CANCER IN ASIA PACIFIC

    Oct 1, 2025, 00:00

  • RWD148 GLOBAL LANDSCAPE OF NOVEL CLINICAL TRIAL DESIGNS: A CROSS-SECTIONAL ANALYSIS OF WHO REGISTERED TRIALS

    Oct 1, 2025, 00:00

  • RWD182 QUANTIFYING THE VALUE OF KNOWING: MEASURING PATIENT COMMUNITY PREFERENCES FOR GENOMIC TESTING IN RARE DISEASES

    Oct 1, 2025, 00:00

  • RWD322 MENTAL HEALTH AS MEDIATOR LINKING AGE-FRIENDLY COMMUNITIES TO CARDIOVASCULAR MULTIMORBIDITY: EVIDENCE FROM A LARGE NATIONAL COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD301 EXPLORING DIAGNOSTIC PATHWAYS AND FACTORS FOR EARLY DETECTION OF LUNG CANCER IN SMALL AND LARGE NODULE PATIENTS

    Oct 1, 2025, 00:00

  • RWD265 A REVIEW OF THE RECENT HISTORY OF THE USE OF RWE IN AUSTRALIAN PBAC DECISION MAKING

    Oct 1, 2025, 00:00

  • RWD296 PRICING, INNOVATION, AND ACCESS-DETERMINANTS OF DRUG REIMBURSEMENT DECISIONS IN TAIWAN’S NHI SYSTEM

    Oct 1, 2025, 00:00

  • RWD201 INCIDENCE, RISK FACTORS, AND TEMPORAL TRENDS OF TONGUE CANCER: A POPULATION-BASED STUDY

    Oct 1, 2025, 00:00

  • RWD85 PRICE VARIATIONS AMONG STANDARDIZED VOLUNTARY HEALTH INSURANCE PLANS: EVIDENCE FROM HONG KONG

    Oct 1, 2025, 00:00

  • RWD20 HOW CAN WE ENHANCE THE USE OF RWE IN REIMBURSEMENT DECISIONS? BEST PRACTICES AND RECOMMENDATIONS

    Oct 1, 2025, 00:00

  • RWD9 A TASK-ORIENTED MULTI-SOURCE HETEROGENEOUS DATA FUSION FRAMEWORK FOR HEALTHCARE AND ELDERLY CARE INTEGRATION

    Oct 1, 2025, 00:00

  • RWD108 COST AND COST-EFFECTIVENESS OF ROBOT-ASSISTED SURGERY (RAS) IN KOREA: AN ECONOMIC REVIEW OF RAS BETWEEN 2007 AND 2025

    Oct 1, 2025, 00:00

  • RWD242 PROPOSAL OF USING CLAIMS-BASED DIAGNOSES AND PRENATAL EXAMINATIONS TO IDENTIFY PREGNANCY IN TAIWAN: NATIONAL HEALTH INSURANCE RESEARCH DATABASE

    Oct 1, 2025, 00:00

  • RWD107 CHARACTERISTICS AND ACCESSIBILITY OF ORPHAN DRUGS THROUGH 2017-2024 NATIONAL DRUG PRICE NEGOTIATION IN CHINA

    Oct 1, 2025, 00:00

  • RWD86 PRELIMINARY REPORT OF SYSTEM DYNAMICS MODELING OF A CO-PAYMENT MECHANISM FOR BREAST CANCER PATIENTS IN MALAYSIA

    Oct 1, 2025, 00:00

  • RWD58 RE-ESTIMATING AN EQ-5D-5L VALUE SET FOR CHINA

    Oct 1, 2025, 00:00

  • RWD10 PREFERENCES FOR ADOPTING ARTIFICIAL INTELLIGENCE IN RADIATION THERAPY TREATMENT: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD39 PREDICTING SURVIVAL IN MULTIPLE MYELOMA PATIENTS WITH DIABETES USING MACHINE LEARNING: A 20-YEAR COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD166 TOWARDS TRUSTWORTHY AND EQUITABLE HEALTHCARE AI: DEFINING FAIRNESS DOMAINS AND METRICS FOR CONSENSUS

    Oct 1, 2025, 00:00

  • RWD141 USING SCALING FACTOR MODEL TO ESTIMATE THE VALUE SET OF PSORIASIS BOLT-ON EQ-5D-5L HEALTH STATES

    Oct 1, 2025, 00:00

  • RWD317 THE BURDEN OF JAPANESE ENCEPHALITIS IN THE ASIA-PACIFIC: INSIGHTS FROM REAL-WORLD DATA

    Oct 1, 2025, 00:00

  • RWD197 COST-EFFECTIVENESS OF PRIMARY AND COMMUNITY CARE PROGRAMMES FOR OSTEOARTHRITIS: A MODELING STUDY USING DATA FROM A MULTI-CENTER NATIONAL PILOT PROGRAM

    Oct 1, 2025, 00:00

  • RWD90 ESTIMATING THE LIFETIME SURVIVAL AND QALYS OF TUMOR-TREATING FIELDS IN COMBINATION WITH TEMOZOLOMIDE FOR GLIOBLASTOMA USING A KOREAN POPULATION

    Oct 1, 2025, 00:00

  • RWD99 ASSESSING THE SOCIOECONOMIC IMPACT OF DUCHENNE MUSCULAR DYSTROPHY ON CARER’S LIFE IN AUSTRALIA: A CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD14 ASSESSMENT OF STROKE PATTERNS AND RISK FACTORS IN NORTHEAST INDIA: A HOSPITAL-BASED PROSPECTIVE STUDY

    Oct 1, 2025, 00:00

  • RWD238 UTILIZATION OF BIOPSY PRIOR LUNG RESECTION: A RETROSPECTIVE ANALYSIS USING JAPAN'S MEDICAL DATA VISION DATABASE (2008-2023)

    Oct 1, 2025, 00:00

  • RWD235 THE SOCIO-ECONOMIC BURDEN OF TERMINAL CANCER: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD231 IMPACT OF CHILD MALTREATMENT ON THE COSTS OF HEALTH SERVICE USE AND PRODUCTIVITY LOSS: FINDINGS FROM THE AUSTRALIAN CHILD MALTREATMENT STUDY

    Oct 1, 2025, 00:00

  • RWD124 IDENTIFYING RISK-FACTORS ASSOCIATED WITH POSTPARTUM DEPRESSION THROUGH CLAIMS DATA IN JAPAN

    Oct 1, 2025, 00:00

  • RWD32 LEVERAGING REAL WORLD RADIATION MEDICINE HEALTH DATA TO DRIVE EVIDENCE-BASED CANCER CARE POLICIES: AN INSIGHTS FROM THE IAEA SUNRISE PROJECT

    Oct 1, 2025, 00:00

  • RWD297 REAL-WORLD EVIDENCE USE IN JAPANESE HTA: INSIGHTS FROM MANUFACTURER SUBMISSIONS AND PUBLIC ANALYSES (2019-2025)

    Oct 1, 2025, 00:00

  • RWD120 PRESCRIPTION TRENDS FOR ADHD MEDICATIONS IN JAPAN, 2018-2023

    Oct 1, 2025, 00:00

  • RWD115 COST-EFFECTIVENESS OF BUPROPION FOR SELF-CARE ADHERENCE AND GLYCAEMIC CONTROL IN MULTIMORBID TYPE 2 DIABETES MELLITUS AND MILD DEPRESSION [ADHERE-DM] – A CROSS-OVER RANDOMIZED CONTROLLED TRIAL-BASED ECONOMIC EVALUATION

    Oct 1, 2025, 00:00

  • RWD324 PERFORMANCE-BASED RISK-SHARING AGREEMENTS TO SUPPORT INNOVATIVE DRUGS ACCESS DECISIONS IN CHINA: A MIXED STUDY DESIGN

    Oct 1, 2025, 00:00

  • RWD176 EVALUATING FIT-FOR-PURPOSE ANONYMIZATION STRATEGIES FOR JAPANESE REAL-WORLD DATA UNDER EU DATA PROTECTION STANDARDS

    Oct 1, 2025, 00:00

  • RWD202 EVALUATION OF THE APPLICATION OF CPR COMPOSITE ERROR ACTION RECOGNITION SYSTEM BASED ON ARTIFICIAL INTELLIGENCE TECHNOLOGY

    Oct 1, 2025, 00:00

  • RWD118 DESIGNING A PHYSICIAN CAPACITY-BASED PAYMENT FRAMEWORK UNDER A GLOBAL BUDGET: INSIGHTS FROM PHYSICIAN-LEVEL CLAIMS DATA

    Oct 1, 2025, 00:00

  • RWD60 AGE DISTRIBUTION OF DISEASE-CAUSAL HPV INFECTION IN WOMEN WITH HIGH-GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA IN KOREA

    Oct 1, 2025, 00:00

  • RWD228 ASSOCIATION BETWEEN ANTICHOLINERGIC BURDEN AND THE RISK OF CARDIOVASCULAR EVENTS IN OLDER ADULTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD165 APPLYING REAL-WORLD EVIDENCE TO NATIONAL HEALTHCARE REIMBURSEMENT DECISION-MAKING: A STUDY ON ASSESSMENT FRAMEWORKS UNDER CHINA’S LECHENG PILOT POLICY

    Oct 1, 2025, 00:00

  • RWD54 EXPLORATORY DESCRIPTIVE ANALYSIS OF PERIOPERATIVE STOMA CARE AND OUTCOMES: COMPARING JAPAN TO GLOBAL AVERAGES

    Oct 1, 2025, 00:00

  • RWD310 HARNESSING AI FOR QUALITY ASSESSMENT IN ECONOMIC LITERATURE REVIEWS: DEVELOPMENT AND TESTING OF DRUMMOND CHECKLIST PROMPTS

    Oct 1, 2025, 00:00

  • RWD159 PREFERENCES AND WILLINGNESS TO PAY FOR MAINTENANCE INHALERS AMONG ADULTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THAILAND: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD5 UNLOCKING THE STRATEGIC POTENTIAL OF REAL-WORLD EVIDENCE IN THE ASIA – PACIFIC PHARMACEUTICAL MARKET: EXECUTIVE INSIGHTS AND COMMERCIAL IMPLICATIONS

    Oct 1, 2025, 00:00

  • RWD249 CRYOBALLOON VERSUS RADIOFREQUENCY ABLATION IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

    Oct 1, 2025, 00:00

  • RWD169 PREVALENCE OF DIFFUSE PARENCHYMAL LUNG DISEASE PATTERNS ON CHEST X-RAY AND REPORTED RESPIRATORY SYMPTOMS AMONG SALON HAIRDRESSERS IN THE NATIONAL CAPITAL REGION: AN ANALYTICAL CROSS-SECTIONAL STUDY

    Oct 1, 2025, 00:00

  • RWD205 COST-EFFECTIVENESS OF CONCURRENT KOREAN AND WESTERN MEDICINE TREATMENT VS. USUAL CARE FOR CAR ACCIDENT-RELATED WHIPLASH INJURIES IN KOREA: A MARKOV MODEL DECISION ANALYSIS

    Oct 1, 2025, 00:00

  • RWD125 INTEGRATING REAL WORLD EVIDENCE IN ECONOMIC EVALUATION OF HERPES ZOSTER VACCINATION AMONG KIDNEY TRANSPLANT PATIENTS IN THAILAND

    Oct 1, 2025, 00:00

  • RWD75 USING REAL WORLD DATA TO ESTIMATE THE COST OF CARDIAC IMPLANTABLE ELECTRONIC DEVICE (CIED) INFECTION IN A HIGH-RISK AUSTRALIAN POPULATION

    Oct 1, 2025, 00:00

  • RWD2 ADOPTION OF RECOMMENDATIONS IN THE REFERENCE FRAMEWORK FOR CHILDREN'S HEALTH IN PRIMARY CARE: A SURVEY OF PRACTICES, BARRIERS, AND ENABLERS AMONG PRIMARY CARE PRACTITIONERS IN HONG KONG

    Oct 1, 2025, 00:00

  • RWD261 MYASTHENIA GRAVIS HEALTHCARE RESOURCE USE AND COST OF THERAPY IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD73 THE SOCIO-ECONOMIC BURDEN OF END-STAGE KIDNEY DISEASE: REAL-WORLD EVIDENCE FROM BULGARIA

    Oct 1, 2025, 00:00

  • RWD110 POLYPHARMACY AND RISK OF MAJOR CARDIOVASCULAR EVENTS AMONG CHINESE PATIENTS WITH DIABETES: A RETROSPECTIVE COHORT STUDY USING INSTRUMENTAL VARIABLE ANALYSIS

    Oct 1, 2025, 00:00

  • RWD313 THE GAP BETWEEN RETAIL PHARMACY PRICES AND GOVERNMENT REFERENCE PRICES IN CHINA: A CASE STUDY OF COMMON STATIN DRUGS

    Oct 1, 2025, 00:00

  • RWD304 PREVALENCE OF INFLUENZA VACCINATION UPTAKE AND HEALTH ATTITUDES AMONG ADULTS IN CHINA: A CHINA NATIONAL HEALTH AND WELLNESS SURVEY STUDY

    Oct 1, 2025, 00:00

  • RWD323 UNLOCKING PREFERENCES FOR WORK-LIFE BALANCE AND FERTILITY POLICIES AMONG WORKING WOMEN IN EAST ASIA: A DISCRETE CHOICE EXPERIMENT

    Oct 1, 2025, 00:00

  • RWD244 BODY WEIGHT-ASSOCIATED DIFFERENCES IN ADVERSE DRUG REACTION PROFILES OF AROMATASE INHIBITORS: A REAL-WORLD PHARMACOVIGILANCE STUDY USING FAERS DATABASE

    Oct 1, 2025, 00:00

  • RWD286 ECONOMIC EVALUATION ON DENTAL CARIES PREVENTIVE INTERVENTIONS FOR CHILDREN USING A PRIORITY-SETTING APPROACH IN AUSTRALIA

    Oct 1, 2025, 00:00

  • RWD281 LEVERAGING NATIONWIDE HEALTH AND INSURANCE RECORDS TO TRACK BIOLOGIC DRUG DIFFUSION IN IBD: A 20-YEAR REAL-WORLD STUDY FROM ISRAEL

    Oct 1, 2025, 00:00

  • RWD208 COST-UTILITY AND BUDGET IMPACT ANALYSIS OF FARICIMAB FOR DIABETIC MACULAR EDEMA (DME) AND NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN INDONESIA

    Oct 1, 2025, 00:00

  • RWD144 PREVALENCE AND HEALTHCARE RESOURCE UTILIZATION TREND IN LUNG CANCER, COLORECTAL CANCER, BREAST CANCER, AND PROSTATE CANCER IN JAPAN 2016–2024

    Oct 1, 2025, 00:00

  • RWD84 PATIENT VOICES IN HEALTH TECHNOLOGY ASSESSMENTS: INSIGHTS FROM AUSTRALIA AND SINGAPORE

    Oct 1, 2025, 00:00

  • RWD246 CONSUMER PREFERENCES FOR ATTRIBUTES AMONG VOLUNTARY HEALTH INSURANCE PLANS: A SYSTEMATIC REVIEW

    Oct 1, 2025, 00:00

  • RWD70 IMPACT OF CHILD MALTREATMENT ON HEALTH-RELATED QUALITY OF LIFE: FINDINGS FROM THE AUSTRALIAN LONGITUDINAL STUDY ON WOMEN’S HEALTH

    Oct 1, 2025, 00:00

  • RWD71 ESTIMATING TREATMENT EFFECT ON SURVIVAL OUTCOMES FROM REAL WORLD DATA: INVERSE PROBABILITY OF TREATMENT WEIGHTING WITH MISSING DATA AND NON-PROPORTIONAL HAZARDS

    Oct 1, 2025, 00:00

  • RWD302 UTILIZATION OF PATIENT-EXPERIENCED DATA IN HEALTH TECHNOLOGY ASSESSMENTS IN ASIA PACIFIC REGION

    Oct 1, 2025, 00:00

  • RWD61 CHARACTERISING THE LATENCY PERIOD OF SECONDARY PRIMARY MALIGNANCY AND LYMPHOMA ONSET FOLLOWING TISAGENLECLEUCEL (CAR-T CELL THERAPY): A REAL-WORLD DATA ANALYSIS

    Oct 1, 2025, 00:00

  • RWD233 CHARACTERISTICS OF AUSTRALIAN PBAC SUBMISSIONS USING RWE

    Oct 1, 2025, 00:00

  • RWD114 PHARMACOLOGICAL AND ELECTRONIC CIGARETTE INTERVENTIONS FOR SMOKING CESSATION IN PREGNANCY: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD269 A MACHINE LEARNING-DRIVEN MULTIDIMENSIONAL EVALUATION OF TANDOSPIRONE FORMULATIONS BASED ON REAL-WORLD EVIDENCE

    Oct 1, 2025, 00:00

  • RWD254 BENEFIT OF IMMEDIATE INITIATION OF NIRMATRELVIR/RITONAVIR AGAINST LONG COVID: REAL-WORLD COHORT STUDY

    Oct 1, 2025, 00:00

  • RWD308 DOES IMPROVED HOSPITAL MANAGEMENT ENHANCE HEALTHCARE EFFICIENCY? EVIDENCE FROM COUNTY-LEVEL HOSPITALS IN CHINA

    Oct 1, 2025, 00:00

  • RWD251 ASSOCIATION OF INITIAL Z-DRUG PRESCRIPTION DURATION AND LONG-TERM USE

    Oct 1, 2025, 00:00

  • RWD311 EXPLORING THE EVALUATION OF NETWORK META-ANALYSIS ASSUMPTIONS: CURRENT APPROACHES AND PRACTICES

    Oct 1, 2025, 00:00

  • RWD116 DISPARITIES IN HEALTH OUTCOMES AND CARE AMONG ALK-POSITIVE NON-SMALL CELL LUNG CANCER PATIENTS: REAL-WORLD EVIDENCE OF SOCIAL DETERMINANTS OF HEALTH

    Oct 1, 2025, 00:00

  • RWD41 REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF FIRST-LINE THERAPIES OF HEPATOCELLULAR CARCINOMA: SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

    Oct 1, 2025, 00:00

  • RWD218 OVERVIEW OF RARE DISEASE PATIENT-CENTERED STUDIES METHODOLOGIES AND RECOMMENDATIONS TO OVERCOME CHALLENGES

    Oct 1, 2025, 00:00

  • RWD203 INEQUALITY AND DETERMINANTS OF ACCESS TO ESSENTIAL ANTICANCER MEDICINES FOR CHILDREN IN CHINA

    Oct 1, 2025, 00:00

  • RWD282 REAL-WORLD PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION OF PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS IN JAPAN: A RETROSPECTIVE CLAIMS ANALYSIS

    Oct 1, 2025, 00:00

  • RWD128 INCORPORATING REAL-WORLD DATA AND MATHEMATICAL MODELING TO ESTIMATE THE UNDIAGNOSED CHRONIC HEPATITIS B POPULATION

    Oct 1, 2025, 00:00

  • RWD154 PREFERENCES AND WILLINGNESS TO PAY FOR MAMMOGRAPHY SCREENING SERVICES AMONG WORKING-AGE URBAN WOMEN IN THAILAND

    Oct 1, 2025, 00:00

  • RWD45 OUT OF POCKET COSTS AND AFFORDABILITY OF AUSTRALIAN EATING DISORDER MEDICARE BENEFITS SCHEME SERVICES USING LINKED DATA

    Oct 1, 2025, 00:00

  • RWD186 A QUALITATIVE STUDY ON OBESE ADULTS’ PERCEPTIONS OF USING ARTIFICIAL INTELLIGENCE FOR WEIGHT MANAGEMENT COUNSELING

    Oct 1, 2025, 00:00

  • RWD314 UNDERSTANDING THE IMPACT OF PATIENT ACTIVATION LEVELS ON ALZHEIMER’S CAREGIVING IN CHINA

    Oct 1, 2025, 00:00

  • RWD198 ESTIMATING THRESHOLD FOR GOOD QUALITY OF LIFE IN AGED CARE RESIDENTS: ANCHOR-BASED CUT-OFF FOR THE QUALITY OF LIFE-AGED CARE CONSUMERS INSTRUMENT

    Oct 1, 2025, 00:00

  • RWD97 THE DIFFERENCE OF COST SAVINGS OF NATIONAL STANDARDIZED HEALTH TRAINING AMONG HEALTH INSURANCE SOCIETIES: A COHORT STUDY USING “WELLNESS-STAR?” HEALTH INSURANCE CLAIMS DATABASE

    Oct 1, 2025, 00:00

  • RWD268 IMPACT OF MEDICAL INSURANCE PRICE NEGOTIATION POLICY ON INNOVATION OF CHINESE LISTED PHARMACEUTICAL COMPANIES: DIFFERENCE-IN-DIFFERENCES ANALYSIS

    Oct 1, 2025, 00:00

  • RWD102 ASSESSING THE COST-UTILITY OF LECANEMAB FOR EARLY ALZHEIMER'S DISEASE TREATMENT AND THE NEED FOR REAL-WORLD EVIDENCE: A SINGAPORE PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD143 ARTIFICIAL INTELLIGENCE ADOPTION IN CLINICAL PRACTICE IN CHINA: PATTERNS AND CHALLENGES

    Oct 1, 2025, 00:00

  • RWD135 TRENDS IN THE INCORPORATION OF CLINICAL OUTCOME ASSESSMENTS IN ASTHMA DRUG DEVELOPMENT IN JAPAN: A FIVE-YEAR REVIEW (2020-2024)

    Oct 1, 2025, 00:00

  • RWD161 COMPARISON OF RISK PREDICTION MODELS FOR KIDNEY DISEASE: AN EXTERNAL VALIDATION USING 0.5 MILLION UK BIOBANK PARTICIPANTS

    Oct 1, 2025, 00:00

  • RWD309 USING REAL WORLD DATA TO ESTIMATE COMPLICATION COSTS FOR A DIABETES COST-EFFECTIVENESS MODEL: AN AUSTRALIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE

    Oct 1, 2025, 00:00

  • RWD48 THE IMPACT OF ENTERAL NUTRITION ON THE SHORT-TERM AND SURVIVAL OUTCOMES OF LUNG CANCER AND BREAST CANCER PATIENTS UNDERGOING MEDICAL TREATMENT

    Oct 1, 2025, 00:00

  • RWD134 EFFECT OF ALK-TKI IN ALK-REARRANGED VERSUS ALK-REARRANGED WITH PD-L1 POSITIVE NSCLC: A TARGET TRIAL EMULATION STUDY

    Oct 1, 2025, 00:00

  • RWD185 CAREGIVERS’ ACCEPTANCE AND PERSPECTIVES ON AN AUGMENTED REALITY-BASED PRESSURE ULCER ASSESSMENT DEVICE: A QUALITATIVE STUDY BASED ON THE TECHNOLOGY ACCEPTANCE MODEL

    Oct 1, 2025, 00:00

  • RWD237 EVALUATING THE HEALTH IMPACT AND COST-EFFECTIVENESS OF GENDER-NEUTRAL VACCINATION OF 9-VALENT HUMAN PAPILLOMAVIRUS VACCINE IN THE PHILIPPINES USING A DYNAMIC TRANSMISSION MODEL

    Oct 1, 2025, 00:00

  • RWD315 COST-EFFECTIVENESS OF CLINICAL BREAST EXAMINATION AS SCREENING MODALITY FOR BREAST CANCER IN VIETNAM: A MARKOV MODELLING

    Oct 1, 2025, 00:00
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »